Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Bronchiolitis obliterans organizing pneumonia (BOOP) after allogeneic bone marrow transplantation].
Nakayama M, Takahashi S, Inoue T, Nagamura F, Setoyama M, Ooi J, Takahashi T, Oshima Y, Miyamoto K, Uemura N, Shindo E, Tajika K, Yanagisawa K, Nagayama H, Okamoto S, Tojo A, Tani K, Ozawa K, Asano S, Wakabayashi T, Sato N, Ichinose Y, Toyama K, Saito H. Nakayama M, et al. Among authors: okamoto s. Rinsho Ketsueki. 1996 Nov;37(11):1271-5. Rinsho Ketsueki. 1996. PMID: 8960660 Japanese.
Recombinant human granulocyte colony-stimulating factor (G-CSF) combined conditioning regimen for allogeneic bone marrow transplantation (BMT) in standard-risk myeloid leukemia.
Takahashi S, Oshima Y, Okamoto S, Nishiwaki K, Nagayama H, Inoue T, Tojo A, Tani K, Asano S. Takahashi S, et al. Among authors: okamoto s. Am J Hematol. 1998 Apr;57(4):303-8. doi: 10.1002/(sici)1096-8652(199804)57:4<303::aid-ajh6>3.0.co;2-y. Am J Hematol. 1998. PMID: 9544974 Free article.
The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation.
Ohashi K, Tanabe J, Watanabe R, Tanaka T, Sakamaki H, Maruta A, Okamoto S, Aotsuka N, Saito K, Nishimura M, Oh H, Matsuzaki M, Takahashi S, Yonekura S. Ohashi K, et al. Among authors: okamoto s. Am J Hematol. 2000 May;64(1):32-8. doi: 10.1002/(sici)1096-8652(200005)64:1<32::aid-ajh6>3.0.co;2-n. Am J Hematol. 2000. PMID: 10815785 Free article. Clinical Trial.
Tacrolimus instead of cyclosporine used for prophylaxis against graft-versus-host disease improves outcome after hematopoietic stem cell transplantation from unrelated donors, but not from HLA-identical sibling donors: a nationwide survey conducted in Japan.
Yanada M, Emi N, Naoe T, Sakamaki H, Takahashi S, Hirabayashi N, Hiraoka A, Kanda Y, Tanosaki R, Okamoto S, Iwato K, Atsuta Y, Hamajima N, Tanimoto M, Kato S. Yanada M, et al. Among authors: okamoto s. Bone Marrow Transplant. 2004 Aug;34(4):331-7. doi: 10.1038/sj.bmt.1704596. Bone Marrow Transplant. 2004. PMID: 15220958
Myeloablative allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: significant roles of total body irradiation and chronic graft-versus-host disease.
Yanada M, Naoe T, Iida H, Sakamaki H, Sakura T, Kanamori H, Kodera Y, Okamoto S, Kanda Y, Sao H, Asai O, Nakai K, Maruta A, Kishi K, Furukawa T, Atsuta Y, Yamamoto K, Tanaka J, Takahashi S. Yanada M, et al. Among authors: okamoto s. Bone Marrow Transplant. 2005 Nov;36(10):867-72. doi: 10.1038/sj.bmt.1705148. Bone Marrow Transplant. 2005. PMID: 16113659
Fasciitis and myositis: an analysis of muscle-related complications caused by chronic GVHD after allo-SCT.
Oda K, Nakaseko C, Ozawa S, Nishimura M, Saito Y, Yoshiba F, Yamashita T, Fujita H, Takasaki H, Kanamori H, Maruta A, Sakamaki H, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT). Oda K, et al. Among authors: okamoto s. Bone Marrow Transplant. 2009 Jan;43(2):159-67. doi: 10.1038/bmt.2008.297. Epub 2008 Sep 1. Bone Marrow Transplant. 2009. PMID: 18762758
Clinical significance of pretransplant serum ferritin on the outcome of allogeneic hematopoietic SCT: a prospective cohort study by the Kanto Study Group for Cell Therapy.
Tanaka M, Kanamori H, Matsumoto K, Tachibana T, Numata A, Ohashi K, Kobayashi T, Nakaseko C, Kanda Y, Yamazaki E, Fujisawa S, Ooi J, Sakura T, Aotsuka N, Onoda M, Machida S, Kato J, Usuki K, Watanabe R, Taguchi J, Yano S, Saito T, Takahashi S, Sakamaki H, Okamoto S; Kanto Study Group for Cell Therapy. Tanaka M, et al. Among authors: okamoto s. Bone Marrow Transplant. 2015 May;50(5):727-33. doi: 10.1038/bmt.2015.17. Epub 2015 Mar 2. Bone Marrow Transplant. 2015. PMID: 25730191 Clinical Trial.
Effect of the order of TBI and cyclophosphamide administration on the outcome of allogeneic hematopoietic stem cell transplantation.
Motohashi K, Fujisawa S, Onizuka M, Kako S, Sakaida E, Shono K, Tatara R, Doki N, Mori T, Sakura T, Aotsuka N, Fuji E, Tomita N, Kawai N, Saitoh T, Usuki K, Taguchi J, Watanabe R, Kobayashi S, Yano S, Kanamori H, Takahashi S, Okamoto S. Motohashi K, et al. Among authors: okamoto s. Bone Marrow Transplant. 2015 Nov;50(11):1476-9. doi: 10.1038/bmt.2015.142. Epub 2015 Jul 20. Bone Marrow Transplant. 2015. PMID: 26191948 No abstract available.
Prospective observational study on the first 51 cases of peripheral blood stem cell transplantation from unrelated donors in Japan.
Goto T, Tanaka T, Sawa M, Ueda Y, Ago H, Chiba S, Kanamori H, Nishikawa A, Nougawa M, Ohashi K, Okumura H, Tanimoto M, Fukuda T, Kawashima N, Kato T, Okada K, Nagafuji K, Okamoto SI, Atsuta Y, Hino M, Tanaka J, Miyamura K. Goto T, et al. Among authors: okamoto si. Int J Hematol. 2018 Feb;107(2):211-221. doi: 10.1007/s12185-017-2341-y. Epub 2017 Oct 13. Int J Hematol. 2018. PMID: 29027623
3,159 results